Skip to NavigationSkip to content

News

UK regulator NICE has announced its decision not to recommend Pfizer’s Xalkori (crizotinib) for use on the NHS in the treatment of ROS1-positive...
Kite’s recent team up with Pfizer looks set to test whether its CAR-T treatment, Yescarto, can be boosted by the latter's monoclonal antibody for the...
AstraZeneca and X-Chem are to expand their existing drug discovery collaboration to focus on the synthesis and delivery of custom libraries, as well...
NICE rejected Janssen’s Darzalex (Daratumumab) back in March last year, concluding that it wasn’t able to accurately determine the efficacy of the...
Evidence is mounting against the efficacy of the common morning sickness pill Diclegis, as new study data reveals that it may not actually aid the...
The standard method of screening for the BRCA gene mutation is to invite women with a family history of either cancer for testing, researchers now...
Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into the benefit of the...
Novartis has revealed that its proposed label expansion for CAR T therapy Kymriah has been accepted under accelerated regulatory pathways on both...
Engineers at the University of Connecticut have developed a biodegradable pressure sensor which is designed to, once ingested, aid in the detection...
Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 billion, and it is...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches